MP20: Prostate Cancer: Basic Research & Pathophysiology I

Podium Session Moderator(s)

• 

  K. Balaji, MD

  Tenured Professor and Chair
  University of Florida, Jacksonville, FL

Poster Session Moderator(s)

• 

  Christopher Evans, MD (he/him/his)

  Retired
  University of California, Davis
• CS

  Christian Stief, MD

  Professor and Chairman
  Dept of Urology, Ludwig Maximilians-University Munich/Germany

Presentations:

• 3:30 PM – 5:30 PM CST

  MP20-01: Protein Kinase D1 (PrKD) protects against DNA damage by increasing α-catenin levels through putative serine681 and 685 phosphorylation of Cyclin Dependent Kinase 12 (CDK12) in prostate cancer (PC)
  

  Poster Presenter: Allison Feibus, MD,MS
• 3:30 PM – 5:30 PM CST

  MP20-02: 27 Hydroxycholesterol and DNA Damage Repair: Implications in Prostate Cancer
  

  Poster Presenter: Nadine Adriana Friedrich, MD
• 3:30 PM – 5:30 PM CST

  MP20-03: microRNA-15b-5p/ Muscarinic receptors/ YAP signaling Contributes to Castration-resistant Growth of Prostate Cancer
  

  Poster Presenter: Yusuke Goto, MD,Phd – Chiba University Graduate School of Medicine
• 3:30 PM – 5:30 PM CST

  MP20-04: ARHGEF2 regulates lineage plasticity promoting neuroendocrine differentiation and treatment resistance in advanced prostate Cancer
  

  Poster Presenter: Shu Ning, PhD (she/her/hers) – University of California Davis
• 3:30 PM – 5:30 PM CST

  MP20-05: Latrophilins as Downstream Effectors of the Androgen Receptor Induce Prostate Cancer Progression
  

  Poster Presenter: Yuki Teramoto
• 3:30 PM – 5:30 PM CST

  MP20-06: Atorvastatin with Degarelix Modulates Tumor Proliferation and the Prostate Tumor Immune Environment in a Myc-CaP/AS Murine Model
  

  Poster Presenter: Ashanda Esdaille, MD (she/her/hers) – Emory University School of Medicine/Atlanta Vetera
• 3:30 PM – 5:30 PM CST

  MP20-07: NPTX1 is a novel serum biomarker induced by ARPI treated prostate cancer and enriched in lineage plasticity with BRN2 high
  

  Poster Presenter: Takeshi Namekawa, MD – Vancouver Prostate Centre
• 3:30 PM – 5:30 PM CST

  MP20-08: Radiotherapy-Induced Urinary Extracellular Vesicles Predict Late Bladder Toxicity in Prostate Cancer Patients
  

  Poster Presenter: Ryan Molony, PHD (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP20-09: Genome-wide CRISPR screens identify novel target genes which alter prostate cancer sensitivity to radiation therapy
  

  Poster Presenter: Koji Hatano (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP20-10: Enzalutamide Increases Prostate Cancer (PCa) Cell Invasion yet Decreases Bladder Cancer (BCa) Cell Invasion via Differentially Regulating the AR/circRNA-ARC1/miR-125b-2-3p or MiR-4736/PPARγ/MMP-9 Signals
  

  Poster Presenter: Yixi Hu (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP20-11: Enzalutamide resistance results in immunosuppressive alterations in prostate tumor immune microenvironment
  

  Poster Presenter: Chengfei Liu, MD – University of California, Davis
• 3:30 PM – 5:30 PM CST

  MP20-12: PiR-hsa-24683 is Essential for Prostate Tumor-Propagating Cells and Promote the Development of Castration Resistance
  

  Poster Presenter: Qiang Peng, MBBS (he/him/his) – The Chinese University of Hongkong
• 3:30 PM – 5:30 PM CST

  MP20-13: Novel platform for MRI-targeted biopsy and sampling of fresh ex-vivo prostate cancer tissue
  

  Poster Presenter: Goran Rac, MD
• 3:30 PM – 5:30 PM CST

  MP20-14: Generation of a new GEMMs model to explore the role of oncofetal Cripto in prostate cancer progression
  

  Poster Presenter: George Niklaus Thalmann, MD (he/him/his) – University of Berne
• 3:30 PM – 5:30 PM CST

  MP20-15: Validation of Artificial Intelligence Diagnostic Support System for Prostate Needle Biopsy
  

  Poster Presenter: Naoto Tokuyama, MD,Phd (he/him/his) – Shin-Yurigaoka
• 3:30 PM – 5:30 PM CST

  MP20-16: Novel function of PTUPB in AKR1C3/AR/AR-V7 axis inhibition and enzalutamide sensitization in advanced prostate cancer
  

  Poster Presenter: Christopher Paul Evans, MD (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP20-17: Lard diet promotes prostate cancer progression through modulating gut microbiota and intratumoral lipid metabolism
  

  Poster Presenter: Hiromi Sato
• 3:30 PM – 5:30 PM CST

  MP20-18: EXOGENOUS NITRIC OXIDE, S-NITROSYLATES THE CSF1 RECEPTOR TO SENSITIZE THE CASTRATION-RESISTANT PROSTATE CANCER CELLS TO CSF1R BLOCKADE
  

  Poster Presenter: Himanshu Arora, PHD, MSC, BS – University of Miami
• 3:30 PM – 5:30 PM CST

  MP20-19: Anti-tumor Effect of Nanaomycin K, a Compound Extracted from Streptomyces, on Prostate Cancer Cell Lines In Vitro and In Vivo
  

  Poster Presenter: Yuto Hirata, MT (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP20-20: Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome and pathway remodeling
  

  Poster Presenter: Nicholas Nikesitch